Over the past 10 years, the group has received more than 2 billion euros from competitive funding for research projects related to technologies for diabetes. The main projects are:
TAILOR – Patient-TAILOREd solutions for blood glucose control in type 1 diabetes. (2020-2023) Reference: PID2019-107722RB-C22. Funded by MICINN. 211.508,00 €. P.I. Josep Vehí. Other researchers: Ningsu Luo, Joaquim Armengol, Remei Calm. Coordinated project (UdG, UPV).
The project TAILOR addresses new technological challenges for automated glucose control in type 1 diabetes aiming at the improvement of glycemic control while matching the patients’ expected interaction with the system, yielding to patient-tailored solutions that maximize perceived usefulness and ease of use to foster the adoption of the technology.
Hypoglycemia Minimizer. (2019-2020) Reference: 2018 PROD 00041. Funded by the European Regional Development Fund (ERDF) of the European Union under the FEDER Operational Program of Catalonia 2014-2020. 99.530,10 €. P.I. Josep Vehí. Other researchers: Iván Contreras.
The HYPOGLYCEMIA MINIMIZER is a software package that can be embedded in any diabetes management app or system, which combines four machine learning approaches to assess the risk of having a hypoglycemic event. At the end of the project we will have a technologically and clinically validated complete prototype.
mSAFE-AP – Solutions for the improvement of efficiency and safety of the artificial pancreas by fault-tolerant multivariable control architectures. (2016-2019) Reference: DPI2016-78831-C2-2-R. Funded by MICINN. 284.350,00 €. P.I. Josep Vehí. Other researchers: Remei Calm, Joaquim Armengol. Coordinated project (UdG, UPV).
The overall objective of this project is the design of an efficient and safe artificial pancreas in normal free-living use, by means of new multivariable reconfigurable fault-tolerant control architectures. As a result of the project, a new smartphone-based multivariable reconfigurable fault-tolerant artificial pancreas system will be built including the methods developed and evaluated in the last phase of the project in a pilot 3-month outpatient study.
CIBERDEM – Incorporation of new groups to the CIBER consortium. (2018-) Reference: CB17/08/00004. Funded by MINECO – Instituto de Salud Carlos III. P.I. Jorge Bondia. Co-PI. Josep Vehí.
Research will be conducted on artificial pancreas and related technologies, such as continuous glucose monitoring and automatic patient monitoring using artificial intelligence techniques.
SAFE-AP – New methods for the efficiency and safety of home artificial pancreas. (2014-2016) Reference: DPI 2013-46982-C2-2-R. MINECO. 204.180,00 €. P.I. Josep Vehí. Other researchers: Remei Calm, Joaquim Armengol, Ningsu Luo. Coordinated project (UdG, UPV).
The aim of SAFE-AP project is to develop methods and tools to improve efficiency and robustness of closed-loop glucose control and continuous glucose monitoring in face of daily life disturbances, in particular meals and exercise. Patient health monitoring and assessment tools are also addressed for the detection of anomalous patient behaviours compromising patient’s safety when using the artificial pancreas at home. Improved models of hypoglycaemia are also being developed.
TecnioSpring – SMART-Diabetes: The Self-Management Assistant and Remote Treatment for Diabetes. (2016-2018) Reference: FP7-PEOPLE-2012-COFUND. European Commission. 96.951,64 €. P.I. Josep Vehí.
A platform integrating existing physiological, psychological and epidemiological models to enable accurate predictions of the health status of the patients, predicting models for the interaction between diabetes and co-morbidities, and personalised strategies to facilitate the behaviour change for a healthier life-style.
DECIPHER – Distributed European Community Individual Patient Healthcare Electronic Record. (2015-2016) Reference: FP7 – 288028. European Commission. 27.830,00 €. P.I: Josep Vehí. Coordinated project (UdG, SocialDiabetes).
The project aims to develop a mobile solution which enables secure cross-border access to existing patient healthcare portals. The new user-friendly application acquired through pre-commercial public procurement (PCP) will enable efficient and safe medical care of mobile patients in EU member states. The objective of the project is to develop a solution addressing the management of patients with chronic long term conditions.
Control of blood glucose in the postprandial period in type 1 Diabetes. Safety and efficacy of a new algorithm in closed loop (artificial pancreas). (2014-2016) Research grant Josep Font 2014. 107.000,00 €. Hospital Clínic Universitari de Barcelona. P.I. Ignacio Conget. Josep Vehí, research team member.
VITALITY – Monitoring & Managing your Health and Well-being. (2011-2014) Reference: IPT-2011-1194-900000. European Commission (ITEA 2 ip10002). MINECO (programa INNPACTO). 158.827,86 €. P.I. Josep Vehí. Other researchers: Remei Calm. Coordinated project.
The objective of VITALITY is to provide a socio-health care solution that provides with a fast response time high quality consolidated data from different applications and sensors, focusing on interoperability and standardization.
CLOSEDLOOP4MEALS – New strategies for post-prandial glycaemic control using insulin pump therapy in type 1 diabetes. (2011-2013) Reference: DPI2010-20764-C02-02. Spanish Ministry of Education and Science. 223.850,00 €. P.I. Josep Vehí. Other researchers: Remei Calm, Joaquim Armengol. Coordinated project (UdG, UPV).
CLOSEDLOOP4MEALS is a research project aiming at the development of new strategies for postprandial glucose control in type 1 diabetes and in-clinic validation. Topics like glucoregulatory modelling, model individualization tools, prediction under intra-patient variability, accuracy improvement of continuous glucose monitoring, robust control algorithms design are addressed to advance towards a safe and efficient artificial pancreas for postprandial control.
SOLARE – Seeking solutions for the artificial pancreas: new methods for improving continuous glucose monitoring and closed loop postprandial glycaemic control.
(2010-2012) Reference: 252085. European Union. FP7-PEOPLE-2009-IEF. Marie
Curie. 160.793,00 €. P.I: Josep Vehí. Coordinated project (UdG, UPV).
INSULAID2 – Closed-loop glucose control in diabetes mellitus 1 and critically ill patients. (2007-2011) Reference: DPI2007-66728. Funded by the Spanish Ministry of Education and Science. 206.063,00 €. P.I: Josep Vehí. Coordinated project (UdG, UPV).